Earlier this year, Eli Lilly's CEO David Ricks told Reuters that the company expects to launch Mounjaro in India as early as 2025 after it clears an ongoing regulatory review.
This animal safety profile is encouraging, but animal safety data does not establish that a compound is safe in humans
Check for transparency about sourcing and manufacturing
Another rare risk is hypokalemia (low potassium), with symptoms like muscle weakness and irregular heartbeat, which can occur when treatment begins for severe anemia
By strengthening the skin barrier, peptides retain moisture and shield against environmental stressors, promoting softer, smoother skin
Many patients discover their insurance significantly reduces or even covers the cost of semaglutide